Organovo Appoints Norman Staskey As CFO
Organovo Holdings, Inc. (ONVO), a clinical-stage biotech firm focused on advancing innovative treatments for inflammatory bowel ...
Organovo, Inc.: Organovo Announces Appointment of Norman Staskey as Chief Financial Officer
Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease ...
Organovo appoints Staskey as Chief Financial Officer
Organovo (ONVO) announced that it had appointed Norman Staskey as Chief Financial Officer. Don't Miss Our New Year's Offers:Discover the ...
Le Lézard3d
NTS and Monkton Partner to Advance Secure Mobile Solutions for Mission-Critical Needs
NTS, a trusted leader in innovative technology products and expertly-managed solutions for defense and intelligence ...
Le Lézard3d
Mission Wealth Announces 2025 Partner Class, Celebrates 25 Years of Innovation
As Mission Wealth proudly enters its 25th year of providing exceptional wealth management services, the firm is thrilled to announce its 2025 Partner Class. These eleven outstanding individuals ...
Organovo Announces Appointment of Norman Staskey as Chief Financial Officer
Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today ...